Section
Money
Earnings analysis, pricing strategy, and financial dynamics
MoneyFierceBiotech ↗
Terremoto Biosciences has spelt out how the California biotech will use a $108 million series C round to conti…
MoneyFierceBiotech ↗
The Spanish government has announced a goal to raise a $200 million venture capital fund to launch the Spain-B…
MoneyFierceBiotech ↗
The former leaders of SpringWorks Therapeutics are back with a new biotech venture that is already buzzing fro…
MoneyFiercePharma ↗
Protagonist Therapeutics-partnered Icotyde has the potential to become one of Johnson & Johnson's "largest…
Money
Backed by Pfizer Ventures and M Ventures, Storm Therapeutics’ $56M Series C funds a Phase 2 sarcoma trial and …
MoneyBriefing
The Waltham-based obesity biotech priced at the top of its range, surpassing Moderna’s 2018 record and signali…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.